Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Randomized Trial of Pembrolizumab & Radiotherapy Versus Radiotherapy in High-Risk Soft Tissue Sarcoma of the Extremity (SU2C-SARC032)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03092323
Recruitment Status : Recruiting
First Posted : March 27, 2017
Last Update Posted : July 6, 2021
Sponsor:
Collaborators:
Stand Up To Cancer
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Sarcoma Alliance for Research through Collaboration

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : July 1, 2024
Estimated Study Completion Date : July 30, 2025